With the Furman Inquiry Panel expected to report imminently and the UK CMA’s digital post-merger review ongoing, our TMT experts look forward to unpicking these developments and a topical discussion with Philip Marsden, Kirsten Edwards-Warren and David Parker.
For more information on this event, click here.
Anticompetitive conduct and patents listed in the Orange Book
Branded pharmaceutical manufacturers are required by law to list all patents in the Orange Book that cover an approved drug product. However,...